Triple-negative breast cancer (TNBC) is a molecular subtype of breast cancer characterized by the lack of immunohistochemical staining for estrogen receptors (ER), progesterone receptors (PR), and lack of overexpression or amplification of human epidermal growth factor receptor 2 (HER2) [2–4]. This evidence concerns the gene ESR1 and breast carcinoma.